carbostyril has been researched along with Hypophosphatemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aghajanian, C; Caird, I; Grisham, RN; Guillen, J; Hensley, ML; Hyman, DM; Iasonos, A; Makker, V; O'Cearbhaill, RE; Rubinstein, MM; Sabbatini, P; Seier, K; Selcuklu, SD; Soldan, K; Tew, WP; Torrisi, J; Troso-Sandoval, T; Won, H; Zimel, C | 1 |
1 trial(s) available for carbostyril and Hypophosphatemia
Article | Year |
---|---|
Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway.
Topics: Aged; Class I Phosphatidylinositol 3-Kinases; Class Ia Phosphatidylinositol 3-Kinase; Endometrial Neoplasms; Enzyme Activation; Female; Humans; Hyperglycemia; Hypoalbuminemia; Hypophosphatemia; Middle Aged; Mutation; Phosphatidylinositol 3-Kinases; Progression-Free Survival; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyridines; Quinolones; Signal Transduction; TOR Serine-Threonine Kinases; Treatment Outcome | 2020 |